Literature DB >> 15071036

DNA polymorphism assay distinguishes isolates of Leishmania donovani that cause kala-azar from those that cause post-kala-azar dermal Leishmaniasis in humans.

Gannavaram Sreenivas1, B V Subba Raju, Ruchi Singh, Angamuthu Selvapandiyan, Robert Duncan, Dwijen Sarkar, Hira L Nakhasi, Poonam Salotra.   

Abstract

Leishmania donovani in India causes visceral infection (kala-azar) and dermal infection (post-kala-azar dermal leishmaniasis). We report here the identification of polymorphism in a well-defined genetic locus among the Leishmania parasites causing the visceral and dermal manifestations, in a comparison of 15 post-kala-azar dermal leishmaniasis and 12 kala-azar patient isolates.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15071036      PMCID： PMC387559          DOI： 10.1128/JCM.42.4.1739-1741.2004

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  19 in total

1.  Characterization of the Leishmania donovani ribosomal RNA promoter.

Authors:  S Yan; M J Lodes; M Fox; P J Myler; K Stuart
Journal:  Mol Biochem Parasitol       Date:  1999-10-15       Impact factor: 1.759

2.  Development of a species-specific PCR assay for detection of Leishmania donovani in clinical samples from patients with kala-azar and post-kala-azar dermal leishmaniasis.

Authors:  P Salotra; G Sreenivas; G P Pogue; N Lee; H L Nakhasi; V Ramesh; N S Negi
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

3.  Leishmania donovani: intraspecific polymorphisms of Sudanese isolates revealed by PCR-based analyses and DNA sequencing.

Authors:  N O El Tai; M El Fari; I Mauricio; M A Miles; L Oskam; S H El Safi; W H Presber; G Schönian
Journal:  Exp Parasitol       Date:  2001-01       Impact factor: 2.011

4.  Genetic typing and phylogeny of the Leishmania donovani complex by restriction analysis of PCR amplified gp63 intergenic regions.

Authors:  I L Mauricio; M W Gaunt; J R Stothard; M A Miles
Journal:  Parasitology       Date:  2001-04       Impact factor: 3.234

5.  Western blot analysis of humoral immune response to Leishmania donovani antigens in patients with post-kala-azar dermal leishmaniasis.

Authors:  P Salotra; A Raina; V Ramesh
Journal:  Trans R Soc Trop Med Hyg       Date:  1999 Jan-Feb       Impact factor: 2.184

6.  Gp63 gene polymorphism and population structure of Leishmania donovani complex: influence of the host selection pressure?

Authors:  S Guerbouj; K Victoir; I Guizani; N Seridi; N Nuwayri-Salti; M Belkaid; R B Ismail; D Le Ray; J C Dujardin
Journal:  Parasitology       Date:  2001-01       Impact factor: 3.234

Review 7.  The increase in risk factors for leishmaniasis worldwide.

Authors:  P Desjeux
Journal:  Trans R Soc Trop Med Hyg       Date:  2001 May-Jun       Impact factor: 2.184

8.  Strain typing in Leishmania donovani by using sequence-confirmed amplified region analysis.

Authors:  Sylke Lewin; Gabriele Schönian; Nahla El Tai; Linda Oskam; Patrick Bastien; Wolfgang Presber
Journal:  Int J Parasitol       Date:  2002-09       Impact factor: 3.981

9.  Persistence without pathology in phosphoglycan-deficient Leishmania major.

Authors:  Gerald F Späth; Lon-Fey Lye; Hiroaki Segawa; David L Sacks; Salvatore J Turco; Stephen M Beverley
Journal:  Science       Date:  2003-08-29       Impact factor: 47.728

Review 10.  Post-kala-azar dermal leishmaniasis.

Authors:  E E Zijlstra; A M Musa; E A G Khalil; I M el-Hassan; A M el-Hassan
Journal:  Lancet Infect Dis       Date:  2003-02       Impact factor: 25.071
View more
  7 in total

1.  Biomarkers of antimony resistance: need for expression analysis of multiple genes to distinguish resistance phenotype in clinical isolates of Leishmania donovani.

Authors:  Dhiraj Kumar; Ruchi Singh; Vasundhra Bhandari; Arpita Kulshrestha; Narendra Singh Negi; Poonam Salotra
Journal:  Parasitol Res       Date:  2012-07       Impact factor: 2.289

2.  Evidence for involvement of TNFR1 and TIMPs in pathogenesis of post-kala-azar dermal leishmaniasis.

Authors:  N A Ansari; G K Katara; V Ramesh; P Salotra
Journal:  Clin Exp Immunol       Date:  2008-12       Impact factor: 4.330

Review 3.  Recent developments leading toward a paradigm switch in the diagnostic and therapeutic approach to human leishmaniasis.

Authors:  Albert Schriefer; Mary E Wilson; Edgar M Carvalho
Journal:  Curr Opin Infect Dis       Date:  2008-10       Impact factor: 4.915

4.  Genetic homogeneity among Leishmania (Leishmania) infantum isolates from dog and human samples in Belo Horizonte Metropolitan Area (BHMA), Minas Gerais, Brazil.

Authors:  Thais Almeida Marques da Silva; Luciana Inácia Gomes; Edward Oliveira; Wendel Coura-Vital; Letícia de Azevedo Silva; Fabiano Sviatopolk-Mirsky Pais; Henrique Gama Ker; Alexandre Barbosa Reis; Ana Rabello; Mariangela Carneiro
Journal:  Parasit Vectors       Date:  2015-04-15       Impact factor: 3.876

Review 5.  Post kala-azar dermal leishmaniasis: A threat to elimination program.

Authors:  Mallikarjuna Rao Gedda; Bhawana Singh; Dhiraj Kumar; Abhishek Kumar Singh; Prasoon Madhukar; Shreya Upadhyay; Om Prakash Singh; Shyam Sundar
Journal:  PLoS Negl Trop Dis       Date:  2020-07-02

6.  Genetic diversity of Leishmania amazonensis strains isolated in northeastern Brazil as revealed by DNA sequencing, PCR-based analyses and molecular karyotyping.

Authors:  João Paulo C de Oliveira; Flora Fernandes; Angela K Cruz; Viviane Trombela; Elisângela Monteiro; Anamaria A Camargo; Aldina Barral; Camila I de Oliveira
Journal:  Kinetoplastid Biol Dis       Date:  2007-06-21

7.  Analysis of genetic polymorphisms and tropism in East African Leishmania donovani by Amplified Fragment Length Polymorphism and kDNA minicircle sequencing.

Authors:  Hanan T Jaber; Asrat Hailu; Francine Pratlong; Patrick Lami; Patrick Bastien; Charles L Jaffe
Journal:  Infect Genet Evol       Date:  2018-07-19       Impact factor: 3.342
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.